Mr. Graham Farrell reports

CIPHER PHARMACEUTICALS SCHEDULES Q3 2025 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the third quarter of 2025 after the market close on Thursday, Nov. 6, 2025. The company will also hold a conference call on Friday, Nov. 7, 2025, at 8:30 a.m. ET, to discuss the results and corporate developments.

Conference call details

Date:  Friday, Nov. 7, 2025

Time:  8:30 a.m. ET

Dial-in number:  416-945-7677 or 888-699-1199

Replay:  289-819-1450 or 888-660-6345

Code:  24367 followed by the pound key

Expires:  Nov. 14, 2025

Webcast:  A webcast will be available.

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early- to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the United States and South America.